Back to Search
Start Over
BENEFIT–RISK PROFILES OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) VS UMEC/VI IN PATIENTS WITH COPD: A MARKOV MODEL.
- Source :
- CHEST; 2020 Supplement, Vol. 158, pA1666-A1671, 6p
- Publication Year :
- 2020
- Subjects :
- MARKOV processes
OBSTRUCTIVE lung diseases
Subjects
Details
- Language :
- English
- ISSN :
- 00123692
- Volume :
- 158
- Database :
- Complementary Index
- Journal :
- CHEST
- Publication Type :
- Academic Journal
- Accession number :
- 146611528
- Full Text :
- https://doi.org/10.1016/j.chest.2020.08.1495